Skip to main content
NTLA logo

NTLA · Intellia Therapeutics, Inc. · Share Buybacks

Track NTLA — free
$9.70 -0.85 (-8.06%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Market Cap
$1.36B
Shares
140.36M
Volume · Nov 13 11.42M Avg daily vol (3M) 4.57M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2022-03-04 $1,035,316,650 $114,683,350 as of 2026-03-02 —
— — — —
Key facts CIK 1652130 CUSIP 45826J105 13F (30d) 249 filings 229 filers Visit website Investor relations